Key Market Indicator:
F&G: 28
25.649,21 NASDAQ · 48.019,01 DOW · 6.864,75 S&P · 4.131,21 Gold · 64,79 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© Globe Newswire
26.09.2025
ISIN: US35168W1036

Fractyl Health Inc
GUTS

LISTED

NASDAQ
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation
News Preview
Pilot study met key 3-month efficacy endpoint with strong statistical significance (p=0.014); Revita-treated patients lost an additional 2.5% total body weight after stopping GLP-1 drugs vs. 10% regain in sham-treated patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: US4158581094

Harrow Inc
HROW

LISTED

NASDAQ
Harrow to Acquire Melt Pharmaceuticals
News Preview
NASHVILLE, Tenn., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has entered into an agreement to acquire Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation f...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: US80303D3052

SANUWAVE Health, Inc.
SNWV

LISTED

NASDAQ
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
News Preview
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
26.09.2025
ISIN: US75886F1075

Regeneron Pharmaceuticals Inc
REGN

LISTED

NASDAQ
Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol
News Preview
FDA approval extends the indication of Evkeeza to treat younger patients with homozygous hypercholesterolemia (HoFH)...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
26.09.2025
ISIN: US7504911022

RadNet Inc
RDNT

LISTED

NASDAQ
RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025
News Preview
LOS ANGELES, Sept. 26, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vi...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: SE0000135485

RaySearch Laboratories AB (publ)
RAY B

LISTED

STO
RaySearch Brings Next-Level Innovation to ASTRO 2025
News Preview
STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce its participation at ASTRO in San Francisco, California, September 28-30, where state of the art innovations will be presented under the global campaign Coding Energy to End Cancer. Attendees can watch demonstrations of the treatment planning system Ra...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: SE0007045414

SciBase Holding AB (publ)
SCIB

LISTED

STO
Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis
News Preview
STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication of a collaborative scientific project with the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, Switzerland. Nevisense and its underlying Ele...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.09.2025
ISIN: US09074F5044

BioVie Inc
BIVI

LISTED

NASDAQ
BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
News Preview
ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, September 27, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estima...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.09.2025
ISIN: US29415J1060

enVVeno Medical Corporation
NVNO

LISTED

NASDAQ
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
News Preview
Watch the "What This Means" video here IRVINE, CA / ACCESS Newswire / September 26, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Robert Berman, Chief Executive Officer of enVVeno Medi...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: AU000000CSL8

CSL Limited
CSL

LISTED

ASX
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
News Preview
FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the treatment of IgA Nephro...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: AU000000CSL8

CSL Limited
CSL

LISTED

ASX
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
News Preview
FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /CNW/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the treatment of IgA Nephropathy (...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US28176E1082

Edwards Lifesciences Corp.
EW

LISTED

NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW)....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
26.09.2025
ISIN: DK0011048619

BioPorto A/S
BIOPOR

LISTED

CPH
BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented
News Preview
September 26, 2025News Release...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.09.2025
ISIN: CH1429326825

Siegfried Holding AG
SFZN

LISTED

SIX
Change in the Chairmanship of the Board of Directors
News Preview
Media Release Zofingen, September 26, 2025 Ad hoc announcement pursuant to Art. 53 Listing Rules Dr. Andreas Casutt (1963) has been a member of the Board of Directors of Siegfried Holding AG (SIX: SFZN) since 2010 and its Chairman since 2014. The attorney and partner at the Zurich law firm Niederer Kraft Frey AG has decided not to stand for re-el......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: FR0010259150

Ipsen SA
IPN

LISTED

EURONEXT
Ipsen et BioLabs Hôtel-Dieu décernent le Golden Ticket Ipsen 2025 à DETERA Therapeutics
News Preview
             ...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: FR0012127173

OSE Immunotherapeutics SA
OSE

LISTED

EURONEXT
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
News Preview
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: CH0029850754

Addex Therapeutics Ltd
ADXN

LISTED

SIX
Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025
News Preview
Geneva, Switzerland, September 26, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its Half-Year and Second Quarter 2025 Financial Results on September 30, 2025 and...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: NL0010696654

Uniqure NV
QURE

LISTED

NASDAQ
uniQure Announces Pricing of Upsized $300 Million Public Offering
News Preview
LEXINGTON, Mass. and AMSTERDAM, Sept. 25, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its previously announced underwritten public offering of 5,789,473 ordinary shares at a public offering price of $4...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: KR7384470001

Coreline Soft Co., Ltd.
384470

LISTED

KOE
Building a National Lung Cancer Screening Model with AI: Early Lessons from Australia
News Preview
BRISBANE, Australia and SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- Coreline Soft announced today it will host an international webinar on Tuesday, October 14, sharing firsthand experiences and insights from the National Lung Cancer Screening Program (NLCSP) in Australia. The event, presented in collaboration with Lungscreen Australia, wil...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US5324571083

Eli Lilly and Co
LLY

LISTED

NYSE
Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
News Preview
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with evidence to support completing course of treatment once amyloid plaques are reduced to minimal levels INDIANAPOLIS, Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the E...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: KYG0405D1051

Angelalign Technology Inc
6699

LISTED

HKSE
Angelalign Technologies Remains Confident in Light of its Competitor's New Complaint and Diversion Tactic
News Preview
SAN CLEMENTE, Calif., Sept. 24, 2025 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") remains confident in its position in light of the fact that industry behemoth Align Technology Inc. (ALGN) has filed another meritless case against Angel, this time with the U.S. International Trade Commission. This is the latest in a barrage of la...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US02155H1014

Altimmune, Inc.
ALT

LISTED

NASDAQ
ALTIMMUNE (NASDAQ: ALT) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by October 6, 2025
News Preview
PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ -- Berger Montague PC is investigating claims under the federal securities laws against Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for obesity and liver disease, including MASH (metabolic dysfunction-associate...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: DK0010272202

Genmab A/S
GMAB

LISTED

CPH
Grant of Restricted Stock Units and Warrants to Employees in Genmab
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US23282W6057

Cytokinetics Inc
CYTK

LISTED

NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
News Preview
LOS ANGELES, Sept. 25, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics " or "the Company") (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commis...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US8051111016

Savara Inc
SVRA

LISTED

NASDAQ
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA
News Preview
LOS ANGELES, Sept. 25, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Savara Inc. ("Savara " or "the Company") (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
ISIN: CA94947L1022

WELL Health Technologies Corp
WELL

LISTED

TSX
WELL Health and WELLSTAR Technologies to Present at The 2025 Cantech Investment Conference in Toronto
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, and its majority-owned subsid...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US98956P1021

Zimmer Biomet Holdings Inc
ZBH

LISTED

NYSE
Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System
News Preview
iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint Infection after total joint replacement WARSAW, Ind., Sept. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical t...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US45685K1025

InfuSystem Holdings Inc
INFU

LISTED

XASE
InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025
News Preview
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, CEO and Barry Steele, Chief Financial Officer, will participate at the 4th Annual ROTH...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: CA23126M1023

Curaleaf Holdings Inc
CURA

LISTED

TSX
Curaleaf to Report Third Quarter 2025 Financial and Operational Results
News Preview
STAMFORD, Conn., Sept. 25, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2025 after market close on November 5...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US5049221055

Labcorp Holdings Inc
LH

LISTED

NYSE
Labcorp to Announce Third Quarter Financial Results on October 28, 2025
News Preview
BURLINGTON, N.C., Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET th...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: CA23126M1023

Curaleaf Holdings Inc
CURA

LISTED

TSX
Curaleaf to Report Third Quarter 2025 Financial and Operational Results
News Preview
STAMFORD, Conn., Sept. 25, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2025 after market close on November 5, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US9224751084

Veeva Systems Inc
VEEV

LISTED

NYSE
Veeva to Host Virtual Investor Day on October 16, 2025
News Preview
PLEASANTON, Calif., Sept. 25, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, October 16, 2025. The event will begin at 1:30 p.m. PT and will conclude at approximately 3:30 p.m. PT. Veeva will broadcast the presentations live on the company's investor relations website, ir.veeva.com, where a link...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US45780L1044

Inogen Inc
INGN

LISTED

NASDAQ
Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer
News Preview
Inogen, Inc. (Nasdaq: INGN), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Naga Rameswamy as Chief Technology Officer, effective September 29, 2025. Mr. Rameswamy joins Inogen from Alcon, where he served as the Vice President and Global Head of Digi...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US3773221029

Glaukos Corp
GKOS

LISTED

NYSE
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today celebrated the groundbreaking of its new state-of-the-art research, development, and manufacturing facility in Huntsville, Alabama. The new site repre...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US53216B1044

LifeMD, Inc.
LFMD

LISTED

NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 25, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LIFEMD, INC. (LFMD), CONTACT THE LAW OF...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US00216W2089

ATI Physical Therapy Inc
ATIP

LISTED

NYSE
ATI Physical Therapy Recognized for Commitment to Safety in Use of Dry Needling
News Preview
'NeedleCert PrivilegePath' drives exceptional learner adoption and clinical consistency DOWNERS GROVE, Ill., Sept. 25, 2025 /PRNewswire/ -- ATI Physical Therapy, a nationally recognized provider of outpatient physical therapy and rehabilitation services, has been named the winner of the Best Training Adoption Award in Absorb Software's 2025 Absor...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US81684M1045

Semler Scientific Inc
SMLR

LISTED

NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Sept. 25, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US7170811035

Pfizer Inc
PFE

LISTED

NYSE
Hearing Against Pfizer Set For 29 September In Contraceptive ‘Depo-Provera’ Multidistrict Litigation Overseen By Levin Papantonio
News Preview
A hearing in the Depo-Provera legal action against Pfizer Inc. (NYSE:PFE) will take place on Monday, 29 September at 9:00am CT in the United States Courthouse in Pensacola, Florida. The hearing will address oral arguments from the plaintiffs and defendants concerning the issue of pre-emption. The pre-emption defence is common in drug litigation. I...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: FR0000121667

EssilorLuxottica SA
EL

LISTED

EURONEXT
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
News Preview
Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US22663K1079

Crinetics Pharmaceuticals Inc
CRNX

LISTED

NASDAQ
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
News Preview
Palsonify is approved by the U.S. FDA to treat adults with acromegaly...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US50127T1097

Kura Oncology Inc
KURA

LISTED

NASDAQ
Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology
News Preview
– KOMET-001 in R/R NPM1-m AML met its primary endpoint with ziftomenib monotherapy demonstrating significant clinical benefit and deep responses –...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA58490H1073

Medicenna Therapeutics Corp
MDNA

LISTED

TSX
Medicenna Announces Results of Annual Meeting of Shareholders
News Preview
Medicenna Announces Results of Annual Meeting of Shareholders...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US68621F1021

Organogenesis Holdings Inc
ORGO

LISTED

NASDAQ
Organogenesis Provides Update on Second Phase 3 ReNu® Study
News Preview
Company maintains confidence in ReNu as innovative pain management therapy...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US29261A1007

Encompass Health Corp
EHC

LISTED

NYSE
Encompass Health Rehabilitation Hospital of Danbury now open in Connecticut
News Preview
The Company's first location in the state is now accepting patients. BIRMINGHAM, Ala. and DANBURY, Conn., Sept. 25, 2025 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of its first location in the state of Connecticut: Encompass Health Rehabilitation Ho...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: IL0006290147

Teva Pharmaceutical Industries Ltd
TEVA

LISTED

TLV
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
News Preview
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial results on Wednesday, November 5, 2025, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day,...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: IL0006290147

Teva Pharmaceutical Industries Ltd
TEVA

LISTED

TLV
Teva Releases Q3 2025 Aide Memoire
News Preview
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2025 Aide Memoire is available on the “Investors” page on its website....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US53216B1044

LifeMD, Inc.
LFMD

LISTED

NASDAQ
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
News Preview
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4th Annual Healthcare Opportunities Conference, which will be held October 9, 2025 at the Metropolitan Club in New York City. Management will hold one-on-one meetings with inv...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US4158581094

Harrow Inc
HROW

LISTED

NASDAQ
Harrow Launches Harrow Access for All (HAFA)
News Preview
HAFA to Expand Harrow’s Innovative Market Access Model Across Ophthalmic Portfolio...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US17166A1016

Cibus Inc
CBUS

LISTED

NASDAQ
Cibus Announces the Election of Kimberly A. Box to Board of Directors
News Preview
Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmers Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its a...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US68404L2016

Option Care Health Inc
OPCH

LISTED

NASDAQ
Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call
News Preview
BANNOCKBURN, Ill., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2025 on Thursday, October 30, 2025 before the m...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US5324571083

Eli Lilly and Co
LLY

LISTED

NYSE
U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
News Preview
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor In the Phase 3 EMBER-3 trial, Inluriyo monotherapy reduced the risk of progression or death by 38% versus endocrine therapy among patients with ESR1-mutated MBC INDIANAPOLIS, Sept. 25, 2025 /PRNews...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA98420N1050

Xenon Pharmaceuticals Inc.
XENE

LISTED

NASDAQ
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
News Preview
VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced that the company will host an investor w...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US1717571079

Cidara Therapeutics, Inc.
CDTX

LISTED

NASDAQ
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
News Preview
- Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US4718712023

Jasper Therapeutics, Inc.
JSPR

LISTED

NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Jasper Therapeutics, Inc. (JSPR) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US16359R1032

Chemed Corp
CHE

LISTED

NYSE
VITAS® Healthcare, Leading Hospice Provider, Named a 2025 Top Workplace in Healthcare by Top Workplaces USA
News Preview
MIRAMAR, Fla., Sept. 25, 2025 /PRNewswire/ -- VITAS Healthcare, the nation's leading provider of end-of-life care, has been named a 2025 Top Workplace in Healthcare by Top Workplaces USA, a national program that honors organizations based solely on employee feedback. VITAS is one of only 57 healthcare organizations nationwide with more than 1,000...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NUTX
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of NUTX during the cla...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US15135B1017

Centene Corp
CNC

LISTED

NYSE
Sunshine Health Awards Over $100,000 in Grants to Strengthen Florida Communities
News Preview
FORT LAUDERDALE. Fla., Sept. 25, 2025 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE: CNC), has awarded $106,000 in "Get to Know Us" grants to 50 nonprofit organizations across Florida that deliver vital programs addressing health-related social needs....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US18507C1036

Clearpoint Neuro Inc
CLPT

LISTED

NASDAQ
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 25, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that Dr. Paul Larson will be joining the company as Chief Medical Officer starting in January 2...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US74834L1008

Quest Diagnostics Inc
DGX

LISTED

NYSE
Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025
News Preview
SECAUCUS, N.J., Sept. 25, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report third quarter 2025 financial results on Tuesday, October 21, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: FR0012127173

OSE Immunotherapeutics SA
OSE

LISTED

EURONEXT
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
News Preview
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 12.11.2025, Calendar Week 46, 316th day of the year, 49 days remaining until EoY.